FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Judith Kroep

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Anatomy

Tumor Cells, Cultured

Co-author Network

Publications

TOP 3
Eveline M Dijkgraaf; Renske Goedemans; Moniek Heusinkveld; Veena Jha; Judith R Kroep; Johan W R Nortier; Bart Tummers; Lisa T C Vogelpoel; Marij J P Welters; Sjoerd H van der burg
Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting m2 macrophages in the tumor microenvironment.
T J A Dekker; G K J Hooijer; Wilma E Mesker; J W R Nortier; Vincent T H B M Smit; R A E M Tollenaar; M J Van de Vijver; Judith R Kroep
Reliability of core needle biopsy for determining ER and HER2 status in breast cancer.
Lizz van der Heijden; Carla S P van Rijswijk; Nick A Athanasou; Kevin M Bradley; P D Sander Dijkstra; Hans Gelderblom; C L Max H Gibbons; A Bass Hassan; Pancras C W Hogendoorn; Judith R Kroep; Remi A Nout; M A J van de Sande
A multidisciplinary approach to giant cell tumors of tendon sheath and synovium--a critical appraisal of literature and treatment proposal.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Judith Kroep (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Eveline M Dijkgraaf; Renske Goedemans; Moniek Heusinkveld; Veena Jha; Judith R Kroep; Johan W R Nortier; Bart Tummers; Lisa T C Vogelpoel; Marij J P Welters; Sjoerd H van der burg
Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting m2 macrophages in the tumor microenvironment.
Cancer research 2013;73(8):2480-92.
2013: T J A Dekker; G K J Hooijer; Wilma E Mesker; J W R Nortier; Vincent T H B M Smit; R A E M Tollenaar; M J Van de Vijver; Judith R Kroep
Reliability of core needle biopsy for determining ER and HER2 status in breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(4):931-7.
2013: Lizz van der Heijden; Carla S P van Rijswijk; Nick A Athanasou; Kevin M Bradley; P D Sander Dijkstra; Hans Gelderblom; C L Max H Gibbons; A Bass Hassan; Pancras C W Hogendoorn; Judith R Kroep; Remi A Nout; M A J van de Sande
A multidisciplinary approach to giant cell tumors of tendon sheath and synovium--a critical appraisal of literature and treatment proposal.
Journal of surgical oncology 2013;107(4):433-45.
2013: E M de Kruijf; T J A Dekker; L J A C Hawinkels; Judith R Kroep; P J K Kuppen; H Putter; Vincent T H B M Smit; P ten Dijke; R A E M Tollenaar; C J H van de Velde; Wilma E Mesker
The prognostic role of TGF-β signaling pathway in breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013;24(2):384-90.
2013: Adrian A Kaptein; Judith R Kroep; Elly Krol-Warmerdam; Corrie Meirink; Gemma Ranke; Lucia Snoei; T Tabei; Willem A van der Kloot; Kazue Yamaoka; Aukje Does; Kenichi Inoue; Hans Nortier
Illness perceptions and quality of life in Japanese and Dutch women with breast cancer.
Journal of psychosocial oncology 2013;31(1):83-102.
2012: L van der Heijden; C S P van Rijswijk; N A Athanasou; K M Bradley; P D Sander Dijkstra; C L M H Gibbons; P C W Hogendoorn; Judith R Kroep; R A Nout; M A J van de Sande
The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis).
The Journal of bone and joint surgery. British volume 2012;94(7):882-8.
2012: Philippe A Cassier; Julien Dômont; Hans Gelderblom; Antoine Italiano; Judith R Kroep; ROBERT G MAKI; Beatrice Seddon; Silvia Stacchiotti; David Thomas; Winette T van der Graaf; Andrew J Wagner; Emmanuelle Bompas; Jean-Yves Blay
Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis.
Cancer 2012;118(6):1649-55.
2012: Marije Slingerland; Judith R Kroep; Astrid N Scholten; GJ Liefers; J W R Nortier
[Pregnancy-associated breast cancer: current opinions on diagnosis and treatment].
Nederlands tijdschrift voor geneeskunde 2012;156(40):A5286.
2012: Tim J A Dekker; Gerrit K J Hooijer; Judith R Kroep; Sybren L Meijer; Wilma E Mesker; Ed Schuuring; Vincent T H B M Smit; Jos Bart; James E Boers; Susan Ter Borg; Joost van Gorp; Jelle Wesseling; Marc J van de Vijver
Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approach.
Breast cancer research : BCR 2012;14(3):R93.
2012: Judith R Kroep
Advances in epithelial ovarian cancer therapy.
Current pharmaceutical design 2012;18(25):3735-40.
2012: Judith R Kroep; Johan W R Nortier
The role of bevacizumab in advanced epithelial ovarian cancer.
Current pharmaceutical design 2012;18(25):3775-83.
2012: Eveline M Dijkgraaf; Johan W R Nortier; Sjoerd H van der burg; Marij J P Welters; Judith R Kroep
Interleukin-6/interleukin-6 receptor pathway as a new therapy target in epithelial ovarian cancer.
Current pharmaceutical design 2012;18(25):3816-27.
2011: Jakob K Anninga; Marta Fiocco; Hans Gelderblom; Pancras C W Hogendoorn; Judith R Kroep; Antoni H M Taminiau; R Maarten Egeler
Chemotherapeutic adjuvant treatment for osteosarcoma: where do we stand?
European journal of cancer (Oxford, England : 1990) 2011;47(16):2431-45.
2011: S van de Ven; T J A Dekker; J W R Nortier; V T H B M Smit; Judith R Kroep
Discordances in ER, PR and HER2 receptors after neoadjuvant chemotherapy in breast cancer.
Cancer treatment reviews 2011;37(6):422-30.
2011: Arwen H Pieterse; Peep F Stalmeier; Judith R Kroep; Anne M Stiggelbout
[Adjuvant cancer treatment: what benefit does the patient consider worthwhile?].
Nederlands tijdschrift voor geneeskunde 2011;155(45):A3905.
2011: Judith R Kroep; M Ouali; Hans Gelderblom; A Le Cesne; T J A Dekker; Martine Van Glabbeke; P C W Hogendoorn; P Hohenberger
First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC soft tissue and bone sarcoma group study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(1):207-14.
2010: M J A de Jonge; Marije Slingerland; Walter J Loos; Erik A C Wiemer; Herman Burger; Ron H J Mathijssen; Judith R Kroep; Margret A G den Hollander; Diane van der Biessen; Mei-Ho Lam; Jaap Verweij; Hans Gelderblom
Early cessation of the clinical development of LiPlaCis, a liposomal cisplatin formulation.
European journal of cancer (Oxford, England : 1990) 2010;46(16):3016-21.
2010: Judith R Kroep; S C Linn; Epie Boven; H J Bloemendal; J Baas; I A M Mandjes; J van den Bosch; W M Smit; H de Graaf; C P Schröder; G J Vermeulen; W C J Hop; J W R Nortier
Lapatinib: clinical benefit in patients with HER 2-positive advanced breast cancer.
The Netherlands journal of medicine 2010;68(9):371-6.
2010: Saskia van de Ven; Judith R Kroep; Neveen Agnes Therese Hamdy; Harm P Sleeboom; Hans W R Nortier
[Antitumour effects of bisphosphonates in breast cancer].
Nederlands tijdschrift voor geneeskunde 2010;154():A1951.
2009: Judith R Kroep; Judith Bovee; Aart van der Molen; Pancras Hogendoorn; Hans Gelderblom
Extra-abdominal subcutaneous metastasis of a gastrointestinal stromal tumor: report of a case and a review of the literature.
Journal of cutaneous pathology 2009;36(5):565-9.
2009: Judith R Kroep; Hans Gelderblom
Diflomotecan, a promising homocamptothecin for cancer therapy.
Expert opinion on investigational drugs 2009;18(1):69-75.
2006: Judith R Kroep; Egbert F Smit; Giuseppe Giaccone; Kasper van der Born; Jos H Beijnen; Cees J van Groeningen; Wim J F van der Vijgh; Pieter E Postmus; HERBERT PINEDO; Godefridus J Peters
Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancer.
Cancer chemotherapy and pharmacology 2006;58(4):509-16.
2005: SM de Lange; Kasper van der Born; Judith R Kroep; Helle Anita Jensen; P Pfeiffer; A Cleverly; Cees J van Groeningen; Godefridus J Peters
No evidence of gemcitabine accumulation during weekly administration.
European journal of clinical pharmacology 2005;61(11):843-9.
2005: Jan P Vandenbroucke; Judith R Kroep
Bortezomib in multiple myeloma.
The New England journal of medicine 2005;353(12):1297-8; author reply 1297-8.
2004: Jennifer Sigmond; Willem J P Loves; Judith R Kroep; Godefridus J Peters
Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR; in relation to enzyme activity.
Nucleosides, nucleotides & nucleic acids 2004;23(8-9):1347-50.
2004: Jennifer Sigmond; Judith R Kroep; Willem J P Loves; Giovanni Codacci-Pisanelli; Godefridus J Peters
Quantitative real time PCR of deoxycytidine kinase mRNA by Light Cycler PCR in relation to enzyme activity and gemcitabine sensitivity.
Cancer letters 2004;213(2):173-9.
2004: SM de Lange; Cees J van Groeningen; Judith R Kroep; Aart van Bochove; J F Snijders; Godefridus J Peters; HERBERT PINEDO; Giuseppe Giaccone
Phase II trial of cisplatin and gemcitabine in patients with advanced gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(3):484-8.
2004: Judith R Kroep; HERBERT PINEDO; Giuseppe Giaccone; Aart van Bochove; Godefridus J Peters; Cees J van Groeningen
Phase II study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):230-5.
2003: Judith R Kroep; Cees J van Groeningen; Miguel A Cuesta; Mikael E Craanen; Otto S Hoekstra; Emile F I Comans; Elisabeth Bloemena; Corneline Hoekstra; Richard P Golding; Jos W R Twisk; Godefridus J Peters; HERBERT PINEDO; Adriaan A Lammertsma
Positron emission tomography using 2-deoxy-2-[18F]-fluoro-D-glucose for response monitoring in locally advanced gastroesophageal cancer; a comparison of different analytical methods.
Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 2003;5(5):337-46.
2003: Clasina L Van der Wilt; Judith R Kroep; Willem J P Loves; Marianne G Rots; Cees J van Groeningen; G J L Kaspers; Godefridus J Peters
Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver.
European journal of cancer (Oxford, England : 1990) 2003;39(5):691-7.
2002: Judith R Kroep; Willem J P Loves; Clasina L Van der Wilt; Enrique Alvarez; Iannis Talianidis; Epie Boven; Boudewijn J M Braakhuis; Cees J van Groeningen; HERBERT PINEDO; Godefridus J Peters
Pretreatment deoxycytidine kinase levels predict in vivo gemcitabine sensitivity.
Molecular cancer therapeutics 2002;1(6):371-6.
2000: Judith R Kroep; Giuseppe Giaccone; C Tolis; Daphne Voorn; Willem J P Loves; C J Groeningen; HERBERT PINEDO; Godefridus J Peters
Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small-cell lung cancer cell lines.
British journal of cancer 2000;83(8):1069-76.
2000: Godefridus J Peters; Clasina L Van der Wilt; Catharina J A Van Moorsel; Judith R Kroep; André Bergman; SP Ackland
Basis for effective combination cancer chemotherapy with antimetabolites.
Pharmacology & therapeutics 2000;87(2-3):227-53.
2000: Catharina J A Van Moorsel; André Bergman; Gijsbert Veerman; Daphne Voorn; Veronique Ruiz van Haperen; Judith R Kroep; HERBERT PINEDO; Godefridus J Peters
Differential effects of gemcitabine on ribonucleotide pools of twenty-one solid tumour and leukaemia cell lines.
Biochimica et biophysica acta 2000;1474(1):5-12.
2000: Clasina L Van der Wilt; Judith R Kroep; André Bergman; Willem J P Loves; E Alvarez; Iannis Talianidis; S Eriksson; Cees J van Groeningen; HERBERT PINEDO; Godefridus J Peters
The role of deoxycytidine kinase in gemcitabine cytotoxicity.
Advances in experimental medicine and biology 2000;486():287-90.
1999: Judith R Kroep; Godefridus J Peters; Catharina J A Van Moorsel; A Catik; Jan B Vermorken; HERBERT PINEDO; Cees J van Groeningen
Gemcitabine-cisplatin: a schedule finding study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(12):1503-10.
1999: Judith R Kroep; Giuseppe Giaccone; Daphne Voorn; Egbert F Smit; Jos H Beijnen; H Rosing; Catharina J A Van Moorsel; Cees J van Groeningen; Pieter E Postmus; HERBERT PINEDO; Godefridus J Peters
Gemcitabine and paclitaxel: pharmacokinetic and pharmacodynamic interactions in patients with non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2190-7.
1999: Catharina J A Van Moorsel; Judith R Kroep; HERBERT PINEDO; Gijsbert Veerman; Daphne Voorn; Pieter E Postmus; Jan B Vermorken; Cees J van Groeningen; Wim J F van der Vijgh; Godefridus J Peters
Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):441-8.
1999: Judith R Kroep; HERBERT PINEDO; Cees J van Groeningen; Godefridus J Peters
Experimental drugs and drug combinations in pancreatic cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10 Suppl 4():234-8.
1998: Judith R Kroep; Catharina J A Van Moorsel; Gijsbert Veerman; Daphne Voorn; R M Schultz; J F Worzalla; LEE TANZER; Ronald L Merriman; HERBERT PINEDO; Godefridus J Peters
Role of deoxycytidine kinase (dCK), thymidine kinase 2 (TK2), and deoxycytidine deaminase (dCDA) in the antitumor activity of gemcitabine (dFdC).
Advances in experimental medicine and biology 1998;431():657-60.
1998: Catharina J A Van Moorsel; Gijsbert Veerman; Jan B Vermorken; Daphne Voorn; Judith R Kroep; André Bergman; HERBERT PINEDO; Godefridus J Peters
Mechanisms of synergism between gemcitabine and cisplatin.
Advances in experimental medicine and biology 1998;431():581-5.